Jefferies analyst Glen Santangelo raised the firm’s price target on Hims & Hers to $25 from $21 and keeps a Hold rating on the shares. A ...

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

The founding coalition members are: Albertsons Companies, Inc., Circle Medical, Foodsmart, hims & hers, Lifepoint Health, Nixon Law Group, Nourish, and Teladoc Health. With RFK, Jr. as head of Health ...

Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made ...

Traders betting against SPY, an exchange traded fund that tracks S&P 500 stocks, racked up more than $6 billion in profits this month.

Passes has announced a new partnership with Wall Street Beats, a prominent financial content platform, in a move that brings ...

The stock market has recently witnessed significant movements among key players in the technology and healthcare sectors.

Eli Lilly’s stock has hit a 52-week low at $697.35, nosediving over 10% this past week, which has investors holding their ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

Shares of technology tumbled with Apple Inc. leading the charge lower. That decline came on the heels of President Donald ...